Forbes -
27 May 2016 19:42
In trading on Friday, the SPDR S&P Pharmaceuticals ETF (XPH) is outperforming other ETFs, up about 1.8% on the day. Components of that ETF showing particular strength include shares of Relypsa (RLYP), up about 14.4% and shares of Intersect ENT (XENT), up about 5.1% on the day.
Share this Article
Comment on this Article
Please to comment